SCHEMBL26481045

SCHEMBL26481045

COc1ccc([C@H]2Oc3cc([C@H]4Oc5cc(C)cc(OC)c5C[C@@H]4O)ccc3O[C@@H]2CO)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 6/20 0.50
▸ MAPT P10636 5/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ THRB P10828 1/20 0.50
▸ PTPN1 P18031 1/20 0.48
▸ CYP2C9 P11712 4/20 0.47
▸ ALOX15 P16050 3/20 0.47
▸ SLCO1B3 Q9NPD5 3/20 0.47
▸ SLCO1B1 Q9Y6L6 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ SLCO2B1 O94956 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ F2 P00734 1/20 0.47
▸ PLAU P00749 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13829275 0.88 CYP3A4 (0.62) CYP3A4MAPTMAPK1THRBALOX15
SCHEMBL23202768 0.86 CYP3A4 (0.56) CYP3A4MAPTMAPK1THRBPTPN1
SCHEMBL26480861 0.80 CYP3A4 (0.67) CYP3A4MAPTMAPK1PTPN1CYP2C9
SCHEMBL21588204 0.80 CYP3A4 (0.67) CYP3A4MAPTMAPK1PTPN1CYP2C9
SCHEMBL12573080 0.78 CYP3A4 (0.61) CYP3A4MAPTMAPK1THRBALDH1A1
SCHEMBL26481102 0.77 DPP4 (0.49) CYP3A4MAPTMAPK1PTPN1CYP2C9
Catechin Tetramethylether SCHEMBL1430853 0.77 CYP3A4 (0.81) CYP3A4MAPTMAPK1THRBALDH1A1
Catechin Tetramethylether SCHEMBL30178011 0.77 CYP3A4 (0.81) CYP3A4MAPTMAPK1THRBALDH1A1
Catechin Tetramethylether SCHEMBL30991591 0.77 CYP3A4 (0.81) CYP3A4MAPTMAPK1THRBALDH1A1
Catechin Tetramethylether SCHEMBL28731348 0.77 CYP3A4 (0.81) CYP3A4MAPTMAPK1THRBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11643405-B2 Compound for treatment or prevention of liver diseases JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) 2023-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11643405-B2 Compound for treatment or prevention of liver diseases SLC10A1, GYS2, CPT1A CYP3A4 187/4885MAPT 1807/4885MAPK1 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback